About RX Cap
RX Cap is a company based in Boston (United States) founded in 2013 by David MacVittie and Sreeram Ramakrishnan. RX Cap has raised $19.66 million across 1 funding round. RX Cap offers products and services including Adherence Monitoring Devices, Proprietary Data Hubs, Software and APIs, and Patient Activation Tools. RX Cap operates in a competitive market with competitors including GoFire, InHandPlus, YOURmeds, Clarest Health and Medsense, among others.
- Headquarter Boston, United States
- Founders David MacVittie, Sreeram Ramakrishnan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Rxcap Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.66 M (USD)
in 1 rounds
-
Latest Funding Round
$19.66 M (USD), Series A
Apr 25, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RX Cap
RX Cap offers a comprehensive portfolio of products and services, including Adherence Monitoring Devices, Proprietary Data Hubs, Software and APIs, and Patient Activation Tools.
Smart caps that track and monitor prescription intake.
Secure systems for data collection and remote monitoring.
Tools for patient activation and care management platforms.
Apps that support patients in managing their medications.
People of RX Cap
Unlock access to complete
Unlock access to complete
Funding Insights of RX Cap
RX Cap has successfully raised a total of $19.66M through 1 strategic funding round. The most recent funding activity was a Series A round of $19.66 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by RX Cap
Investment portfolio details for RX Cap
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RX Cap
Detailed financials for RX Cap
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rx Cap Comparisons
Peer comparison for RX Cap
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RX Cap
RX Cap operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GoFire, InHandPlus, YOURmeds, Clarest Health and Medsense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smart vaporizer for delivery of essential oils for alternative medicine therapy
|
|
| Locked | Locked | Locked |
Provider of AI-based smartwatch and app for medication management
|
|
| Locked | Locked | Locked |
Provider of smart devices for medication management system
|
|
| Locked | Locked | Locked |
Offers medication management services for patients, caregivers, and healthcare facilities.
|
|
| Locked | Locked | Locked |
Medication management and adherence tools are provided for users.
|
Detailed competitors of RX Cap
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rx Cap
Complete news archive for RX Cap
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RX Cap
RX Cap was founded in 2013 and raised its 1st funding round 11 years after it was founded.
RX Cap is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Sreeram Ramakrishnan is the current CEO of RX Cap. They have also founded this company.
RX Cap is a funded company, having raised a total of $19.66M across 1 funding round to date.
RxCap was founded in 2013 in Boston, United States, as a provider in the health technology sector focused on medication management. A cap specs device is offered alongside a mobile app to support patient adherence. Operations include integration of features such as LED lighting, temperature sensing, rechargeable USB power, child safety locking, optional NFC, and Bluetooth connectivity. Solutions are designed for comprehensive adherence tracking in the pharmaceutical and healthcare fields.
RX Cap's top competitors include YOURmeds, GoFire and InHandPlus.
RX Cap offers Adherence Monitoring Devices, Proprietary Data Hubs, Software and APIs, and Patient Activation Tools.